Featured Research

from universities, journals, and other organizations

Calcium-Blocker Drug Slows Artery Clogging Better Than Beta Blocker

Date:
October 28, 2002
Source:
American Heart Association
Summary:
High blood pressure treatment with a calcium channel antagonist slowed progression of atherosclerosis, the disease process responsible for heart attacks and strokes, better than a beta blocker, according to a rapid track report posted online this week in Circulation: Journal of the American Heart Association.

DALLAS, Oct. 22 – High blood pressure treatment with a calcium channel antagonist slowed progression of atherosclerosis, the disease process responsible for heart attacks and strokes, better than a beta blocker, according to a rapid track report posted online this week in Circulation: Journal of the American Heart Association.

Rapid track articles are released online early because Circulation editors believe the work has major clinical impact or represents important basic science discoveries.

The study tested two high blood pressure medications: lacidipine, a calcium channel blocker, and atenolol, a beta blocker. Beta blockers reduce the heart's tendency to beat faster as it tries to compensate for weakened pumping ability. Allowing the heart to maintain a slower rate lowers blood pressure. Calcium channel blockers interfere with calcium's role in the contraction of these muscles. This causes the muscles to relax, lowering blood pressure and improving blood circulation in the heart.

Ultrasound images taken at the start of the study revealed that patients had measurable atherosclerosis in the carotid arteries. After four years of treatment, the yearly progression rate for this narrowing was 40 percent lower in lacidipine-treated patients than in the patients treated with atenolol.

Researchers tracked plaque progression by measuring intima-media thickness (IMT) in participants' carotid arteries, which carry blood to the brain. IMT is a measurement of the interior lining of blood vessels. During the four-year study, researchers found that people taking atenolol showed an increase in IMT by 0.0145 millimeters per year (mm/yr), while IMT in people taking lacidipine increased by 0.0087 mm/yr.

Alberto Zanchetti, M.D., lead researcher of the European Lacidipine Study on Atherosclerosis (ELSA), says this difference was apparent even though average ambulatory blood pressure reduction among patients taking lacidipine was less than the average reduction achieved by patients taking atenolol.

Zanchetti, who is a professor of medicine at the University of Milan and scientific director of Istituto Auxologico Italiano in Milan, says the finding suggests "it is some specific property of the calcium antagonist we have used in addition to the lowering of blood pressure, that slows down the progression of atherosclerosis."

Calcium channel blockers, also called calcium antagonists, decrease the rate at which calcium flows into the heart and blood vessel walls. This, says Zanchetti, appears to have the beneficial effect of slowing the growth of cells that line the blood vessels and arteries and reducing the size of plaques, the fat deposits that accumulate in arteries.

The report shows that 19.8 percent of the lacidipine-treated patients had a regression of arterial plaque after four years treatment, while 15.7 percent of patients taking atenolol had a similar regression.

The study recruited 2,334 patients with systolic (the top number in a blood pressure reading) pressures ranging from 150-210 millimeters of mercury (mm Hg) and diastolic (the bottom number) pressures ranging from 95 to 115 mm Hg. High blood pressure is defined in an adult as a systolic pressure of 140 mm Hg or higher and/or a diastolic pressure of 90 mm Hg or higher.

The patients' ages ranged from 45 to 75 and they lived in France, Germany, Greece, Italy, Spain, Sweden and the United Kingdom. Patients were randomized to either lacidipine or atenolol once a day. After a month of treatment, if diastolic pressure didn't drop by at least 5 mm Hg to less than 95 mm Hg both drugs were increased and when necessary, a diuretic was added. Patients underwent ultrasound scanning of carotid arteries to measure the thickness of the arterial wall at baseline and every year throughout the study.

When blood pressure was measured in the clinic the drugs achieved virtually the same reductions. When it was monitored using special round-the-clock ambulatory monitoring devices, patients taking atenolol reduced systolic blood pressure an average of 10.3 mm Hg and decreased diastolic pressure by almost 9 mm Hg, while the reduction in the lacidipine group was less: 6.8 mm Hg and 4.9 mm Hg average declines in systolic and diastolic pressures respectively.

Lacidipine is not approved for use in the United States and Zanchetti says it is unknown if other calcium antagonists would be as effective at slowing atherosclerosis. The drug targets dangerous fats that accumulate in the arterial wall and binds with vascular cells.

"So it may be more powerful than other calcium antagonists," he says.

Co-authors are M. Gene Bond, Ph.D.; Michael Hennig, Ph.D., Albrecht Neiss, Ph.D.; Guiseppe Mancia, M.D.; Cesare Dal Palω, M.D.; Lennart Hansson, M.D.; Bruno Magnani, M.D.; Karl-Heinz Rahn, M.D.; John L. Reid, M.D.; Josθ Rodcio, M.D.; Michel Safar, M.D.; Lothar Eckes, M.D., Ph.D.; and Paolo Rizzini, M.D.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "Calcium-Blocker Drug Slows Artery Clogging Better Than Beta Blocker." ScienceDaily. ScienceDaily, 28 October 2002. <www.sciencedaily.com/releases/2002/10/021025065237.htm>.
American Heart Association. (2002, October 28). Calcium-Blocker Drug Slows Artery Clogging Better Than Beta Blocker. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2002/10/021025065237.htm
American Heart Association. "Calcium-Blocker Drug Slows Artery Clogging Better Than Beta Blocker." ScienceDaily. www.sciencedaily.com/releases/2002/10/021025065237.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) — The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) — An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) — Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Fauci: Ebola Protocols to Focus on Training

Fauci: Ebola Protocols to Focus on Training

AP (Oct. 20, 2014) — Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, says he expects revised CDC protocols on Ebola to focus on training, observation and ensuring health care workers are more protected. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins